KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Liabilities and Shareholders Equity (2017 - 2025)

Historic Liabilities and Shareholders Equity for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to $13.6 billion.

  • Elanco Animal Health's Liabilities and Shareholders Equity rose 201.76% to $13.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $52.8 billion, marking a year-over-year decrease of 465.47%. This contributed to the annual value of $12.6 billion for FY2024, which is 1217.1% down from last year.
  • As of Q3 2025, Elanco Animal Health's Liabilities and Shareholders Equity stood at $13.6 billion, which was up 201.76% from $13.7 billion recorded in Q2 2025.
  • In the past 5 years, Elanco Animal Health's Liabilities and Shareholders Equity registered a high of $17.0 billion during Q1 2021, and its lowest value of $12.6 billion during Q4 2024.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $14.9 billion (2022), whereas its average is $14.9 billion.
  • As far as peak fluctuations go, Elanco Animal Health's Liabilities and Shareholders Equity soared by 7464.43% in 2021, and later tumbled by 1286.4% in 2024.
  • Elanco Animal Health's Liabilities and Shareholders Equity (Quarter) stood at $16.5 billion in 2021, then fell by 5.99% to $15.5 billion in 2022, then decreased by 7.29% to $14.4 billion in 2023, then decreased by 12.17% to $12.6 billion in 2024, then grew by 7.43% to $13.6 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $13.6 billion for Q3 2025, versus $13.7 billion for Q2 2025 and $12.9 billion for Q1 2025.